鞘氨醇激酶1对氧自由基诱导心肌细胞损伤的保护作用研究

来源 :军事医学科学院院刊 | 被引量 : 0次 | 上传用户:crazy5555
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:研究鞘氨醇激酶1(SPK1)在氧自由基诱导心肌细胞损伤过程中的作用。方法:分离培养Wistar乳大鼠心肌细胞,用不同浓度过氧化氢(H2O2,0,50,100,200,400μmol/L)处理细胞,检测乳酸脱氢酶(LDH)的释放和细胞SPK1酶活性变化;Northern印迹方法分析SPK1催化产物1-磷酸鞘氨醇(S1P)受体的表达。用S1P预处理心肌细胞,然后加入100μmol/L的H2O2继续作用48h,检测细胞培养上清中LDH的活性;用携带人SPK1基因的复制缺陷型重组腺病毒载体(Ad-SPK1)感染Wistar乳大鼠心肌细胞,然后加入100μmol/L的H2O2继续作用48h,检测细胞培养上清中LDH的活性。分析外源性S1P或SPK1高表达对H2O2诱导心肌细胞损伤的保护作用。结果:H2O2作用于心肌细胞后,导致LDH释放增多,SPK1酶活性抑制,其作用呈剂量依赖性;H2O2刺激使S1P受体Edg-1表达水平升高,Edg-3表达水平降低。外源性S1P预处理使H2O2诱导的LDH释放减少,其作用呈剂量依赖性。与对照组相比,Ad-SPK1感染使心肌细胞SPK1酶活性明显升高,细胞培养上清中S1P含量增多,并明显抑制H2O2诱导心肌细胞LDH的释放。结论:SPK1高表达能保护H2O2导致的心肌细胞死亡,这种保护作用主要通过S1P的释放来实现。Edg-1和Edg-3可能参与SPK1对心肌细胞的保护作用。 Objective: To investigate the role of sphingosine kinase 1 (SPK1) in cardiomyocyte injury induced by oxygen free radicals. Methods: Myocardial cells from Wistar rats were isolated and cultured. The cells were treated with different concentrations of H2O2 (0, 50, 100, 200 and 400μmol / L) to detect the release of lactate dehydrogenase (LDH) and the activity of SPK1. Northern blotting The SPK1 catalytic product, sphingosine-1-phosphate (S1P) receptor expression was analyzed. Cardiomyocytes were pretreated with S1P, then treated with 100μmol / L H2O2 for 48h, the activity of LDH in the cell culture supernatant was detected. Wistar milk was infected with replication-defective recombinant adenovirus carrying human SPK1 gene (Ad-SPK1) Rat cardiomyocytes, and then add 100μmol / L H2O2 for 48h, detect the activity of LDH in the cell culture supernatant. The protective effect of exogenous S1P or SPK1 expression on H2O2-induced cardiomyocyte injury was analyzed. Results: After H2O2 treatment, the release of LDH was increased and the activity of SPK1 was inhibited in a dose-dependent manner. H2O2 stimulation increased the expression of Edg-1 on S1P receptor and decreased the expression of Edg-3. Exogenous S1P preconditioning reduced H2O2-induced LDH release in a dose-dependent manner. Compared with the control group, Ad-SPK1 infection significantly increased SPK1 activity in cardiomyocytes, increased S1P content in the cell culture supernatant, and significantly inhibited the release of LDH from H2O2-induced cardiomyocytes. Conclusion: High expression of SPK1 can protect cardiomyocytes from H2O2-induced apoptosis. This protective effect is mainly achieved through the release of S1P. Edg-1 and Edg-3 may participate in the protective effect of SPK1 on cardiomyocytes.
其他文献
目的:分析幼儿急疹的早期临床特点。方法136例幼儿急疹患儿,对其临床表现、实验室检查及治疗情况进行分析。结果136例均有发热,热程3~5 d,热退疹出,可伴随咳嗽、流涕、呕吐、
阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是一种以睡眠过程中频繁发生呼吸暂停或低通气,并有血氧饱和度下降为特征的临床综合征[1]。OSAHS的主要特点在于频发睡眠呼吸暂停和低通
目的 观察硝普钠联合多巴胺治疗急性心力衰竭的效果。方法 88例急性心力衰竭(AHF)患者,按照随机数字表方法分成对照组与观察组,每组44例。对照组采用常规方法治疗。观察组在常
推进农业现代化进程是我国欠发达地区培育和发展自身竞争比较优势和核心竞争力,实现全面建设小康社会目标的基础.本文先着重分析了在我国欠发达地区农业现代化进程中存在的农
目的研究曲尼司特联合缬沙坦治疗难治性Ig A肾病效果及安全性。方法 127例难治性Ig A肾病患者,按治疗用药不同分为实验组(67例)和对照组(60例)。对照组采用传统治疗方法单用
目的研究采用阿托伐他汀钙治疗慢性充血性心力衰竭的临床效果。方法 100例慢性充血性心力衰竭患者,随机分为观察组与对照组,各50例,对照组采取充血性心力衰竭常规治疗,观察组
目的观察联合吸入噻托溴铵及沙美特罗丙酸氟替卡松治疗慢性阻塞性肺疾病患者的临床效果。方法 100例慢性阻塞性肺疾病患者,随机分成对照组和观察组,每组50例,对照组患者给予
目的通过乌司他汀、生长抑素联合治疗重度急性胰腺炎的疗效观察,探讨有效的治疗方案。方法 86例重度急性胰腺炎患者作为研究对象,按照随机数字表法分为治疗组43例和对照组43
目的探讨尤瑞克林治疗急性脑梗死的疗效及安全性。方法 86例急性脑梗死患者静脉滴注尤瑞克林0.15 PNA+0.9%生理盐水100 ml,给药1次/d,连续滴注7~14 d;采用神经功能缺损评分(N
目的:研究不同剂量阿托伐他汀对轻度冠状动脉粥样硬化的疗效,并评价其安全性。方法88例轻度冠状动脉粥样硬化(冠状动脉狭窄程度低于30%)患者,随机分为观察组和对照组,各44例,均予